U.S. markets open in 59 minutes

Supernus Pharmaceuticals, Inc. (SUPN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
28.31+0.20 (+0.71%)
At close: 4:00PM EDT

28.40 +0.09 (0.32%)
Pre-Market: 8:14AM EDT

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 4/11/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
1.50B1.33B1.10B1.25B945.14M
Enterprise Value 3
1.49B1.39B1.13B1.23B976.51M
Trailing P/E
12.0010.449.4711.008.57
Forward P/E 1
20.16N/AN/A21.7915.13
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
2.922.832.643.172.47
Price/Book (mrq)
2.011.881.652.041.59
Enterprise Value/Revenue 3
2.869.707.309.7310.28
Enterprise Value/EBITDA 7
7.0826.9317.0621.8826.74

Trading Information

Stock Price History

Beta (5Y Monthly) 1.20
52-Week Change 351.31%
S&P500 52-Week Change 349.51%
52 Week High 331.99
52 Week Low 317.20
50-Day Moving Average 326.84
200-Day Moving Average 324.68

Share Statistics

Avg Vol (3 month) 3597.3k
Avg Vol (10 day) 31.02M
Shares Outstanding 552.92M
Implied Shares Outstanding 6N/A
Float 47.91M
% Held by Insiders 13.61%
% Held by Institutions 1104.40%
Shares Short (Mar 14, 2021) 47.47M
Short Ratio (Mar 14, 2021) 411.49
Short % of Float (Mar 14, 2021) 421.07%
Short % of Shares Outstanding (Mar 14, 2021) 414.12%
Shares Short (prior month Feb 11, 2021) 47.15M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 24.40%
Operating Margin (ttm)36.15%

Management Effectiveness

Return on Assets (ttm)8.82%
Return on Equity (ttm)18.94%

Income Statement

Revenue (ttm)520.4M
Revenue Per Share (ttm)9.89
Quarterly Revenue Growth (yoy)42.90%
Gross Profit (ttm)467.94M
EBITDA 206.24M
Net Income Avi to Common (ttm)126.95M
Diluted EPS (ttm)2.36
Quarterly Earnings Growth (yoy)-7.10%

Balance Sheet

Total Cash (mrq)422.53M
Total Cash Per Share (mrq)7.98
Total Debt (mrq)418.09M
Total Debt/Equity (mrq)56.13
Current Ratio (mrq)2.57
Book Value Per Share (mrq)14.09

Cash Flow Statement

Operating Cash Flow (ttm)138.4M
Levered Free Cash Flow (ttm)148.06M